See more : MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) Income Statement Analysis – Financial Results
Complete financial analysis of ShenZhen Consys Science & Technology Co., Ltd. (688788.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ShenZhen Consys Science & Technology Co., Ltd., a leading company in the Aerospace & Defense industry within the Industrials sector.
- Asia Properties, Inc. (ASPZ) Income Statement Analysis – Financial Results
- SOCAR Inc. (403550.KS) Income Statement Analysis – Financial Results
- Adani Energy Solutions Limited (ADANIENSOL.BO) Income Statement Analysis – Financial Results
- Portillo’s Inc. (PTLO) Income Statement Analysis – Financial Results
- Evolus, Inc. (EOLS) Income Statement Analysis – Financial Results
ShenZhen Consys Science & Technology Co., Ltd. (688788.SS)
About ShenZhen Consys Science & Technology Co., Ltd.
Shenzhen Consys Science & Technology Co., Ltd. engages in research & development, production and sales of military electronic information equipment and related modules. Its products include command and control information processing equipment, software radar information processing equipment, portable wireless command terminal, and other information equipment such as processing terminals and special modules. The company was founded on February 27, 2004 and is headquartered in Shenzhen, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 236.29M | 233.31M | 610.30M | 654.93M | 674.38M | 551.38M | 33.66M |
| Cost of Revenue | 125.60M | 101.16M | 184.41M | 202.53M | 203.25M | 185.79M | 15.14M |
| Gross Profit | 110.69M | 132.15M | 425.89M | 452.40M | 471.13M | 365.59M | 18.52M |
| Gross Profit Ratio | 46.84% | 56.64% | 69.78% | 69.08% | 69.86% | 66.30% | 55.03% |
| Research & Development | 246.40M | 203.45M | 198.58M | 181.69M | 117.71M | 56.73M | 43.64M |
| General & Administrative | 17.98M | 15.86M | 14.77M | 28.87M | 14.47M | 7.16M | 3.93M |
| Selling & Marketing | 7.60M | 21.39M | 21.84M | 21.62M | 15.92M | 8.87M | 4.15M |
| SG&A | 25.58M | 37.26M | 36.61M | 50.49M | 30.39M | 16.03M | 8.08M |
| Other Expenses | 65.23M | 27.41M | 20.18M | 21.34M | 25.10M | -47.25K | 244.73K |
| Operating Expenses | 337.21M | 268.11M | 255.37M | 253.52M | 173.20M | 91.98M | 57.31M |
| Cost & Expenses | 462.81M | 369.27M | 439.78M | 456.04M | 376.46M | 277.77M | 72.45M |
| Interest Income | 32.08M | 39.85M | 40.00M | 8.72M | 686.31K | 204.06K | 545.33K |
| Interest Expense | 2.66M | 877.56K | 1.18M | 8.86M | 8.03M | 1.28M | 0.00 |
| Depreciation & Amortization | 62.72M | 29.22M | 21.31M | 9.61M | 8.10M | 6.63M | 4.26M |
| EBITDA | -161.23M | -180.07M | 212.31M | 211.60M | 257.99M | 244.06M | -38.69M |
| EBITDA Ratio | -68.23% | -29.44% | 37.83% | 33.85% | 45.01% | 50.26% | -105.94% |
| Operating Income | -232.92M | -135.97M | 185.78M | 187.45M | 244.52M | 238.30M | -43.19M |
| Operating Income Ratio | -98.57% | -58.28% | 30.44% | 28.62% | 36.26% | 43.22% | -128.32% |
| Total Other Income/Expenses | 6.31M | 46.49M | 2.36M | 5.02M | -7.93M | 248.42K | 244.73K |
| Income Before Tax | -226.61M | -211.82M | 185.47M | 192.47M | 244.43M | 238.25M | -42.95M |
| Income Before Tax Ratio | -95.90% | -90.79% | 30.39% | 29.39% | 36.25% | 43.21% | -127.60% |
| Income Tax Expense | -5.07M | -15.87M | 9.10M | 16.76M | 27.97M | 33.09M | -6.16M |
| Net Income | -203.26M | -195.95M | 178.49M | 177.06M | 217.97M | 207.36M | -36.35M |
| Net Income Ratio | -86.02% | -83.99% | 29.25% | 27.04% | 32.32% | 37.61% | -108.00% |
| EPS | -1.93 | -1.85 | 1.69 | 1.67 | 2.06 | 2.71 | -0.47 |
| EPS Diluted | -1.93 | -1.85 | 1.69 | 1.67 | 2.06 | 2.71 | -0.47 |
| Weighted Avg Shares Out | 105.56M | 105.75M | 105.75M | 105.75M | 105.75M | 76.60M | 76.60M |
| Weighted Avg Shares Out (Dil) | 105.56M | 105.75M | 105.75M | 105.75M | 105.75M | 76.60M | 76.60M |
Source: https://incomestatements.info
Category: Stock Reports